Successful Transfer of Late Phase Eosinophil Infiltration in the Lung by Infusion of Helper T Cell Clones

American Journal of Respiratory Cell and Molecular Biology

Volumn 16, Issue 4, 1997, Pages 448-454

  Kaminuma, Osamu ^a   Mori, Akio ^b   Ogawa, Koji ^b   Nakata, Aya ^b   Kikkawa, Hideo ^b   Naito, Kazuaki ^b   Suko, Matsunobu ^b   Okudaira, Hirokazu ^b  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHUS;

ANTIBODY; CYTOKINE; INTERLEUKIN 5;

ANIMAL; ARTICLE; ASTHMA; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL CLONE; CELL TRANSPLANTATION; EOSINOPHILIA; IMMUNOLOGY; LUNG; LUNG LAVAGE; MALE; METABOLISM; MOUSE; MUCOSA; PATHOLOGY; TH2 CELL; TRANSPLANTATION;

ANIMALS; ANTIBODIES; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CELL TRANSPLANTATION; CLONE CELLS; CYTOKINES; EOSINOPHILIA; INTERLEUKIN-5; LUNG; MALE; MICE; MICE, INBRED BALB C; MUCOUS MEMBRANE; TH2 CELLS;

EID: 0031110550     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.16.4.9115756     Document Type: Article

References (45)

1. Corrigan, C. J., and A. B. Kay. 1992. T cells and eosinophils in the pathogenesis of asthma. Immunol. Today 13:501-507.
2. Frick, W. E., J. B. Sedgwick, and W. W. Busse. 1989. The appearance of hypodense eosinophils in antigen-dependent late phase asthma. Am. Rev. Respir. Dis. 139:1401-1406.
3. Bousquet, J., P. Chanez, J. Y. Lacoste, G. Barneon, N. Ghavanian, I. Enander, P. Venge, S. Ahlstedt, J. Simony Lafontaine, P. Godard, and F. B. Michel. 1990. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323:1033-1039.
4. Frigas, E., and G. J. Gleich. 1986. The eosinophil and the pathophysiology of asthma. J. Allergy Clin. Immunol. 77:527-537.
5. +) cells and eosinophils in allergy and asthma. Am. Rev. Respir. Dis. 145:S22-S26.
6. Hamid, Q., M. Azzawi, S. Ying, R. Moqbel, A. J. Wardlaw, C. J. Corrigan, B. Bradley, S. R. Durham, J. V. Collins, P. K. Jeffery, J. Quint, and A. B. Kay. 1991. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J. Clin. Invest. 87:1541-1546.
7. Okudaira, H., M. Nogami, G. Matsuzaki, M. Dohi, M. Suko, S. Kasuya, and K. Takatsu. 1991. T-cell-dependent accumulation of eosinophils in the lung and its inhibition by monoclonal anti-interleukin-5. Int. Arch. Allergy Appl. Immunol. 94:171-173.
8. Azzawi, M., B. Bradley, P. K. Jeffery, A. J. Frew, A. J. Wardlaw, G. Knowles, B. Assoufi, J. V. Collins, S. Durham, and A. B. Kay. 1990. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am. Rev. Respir. Dis. 142:1407-1413.
9. Metzger, W. J., D. Zavala, H. B. Richerson, P. Moseley, P. Iwamota, M. Monick, K. Sjoerdsma, and G. W. Hunninghake. 1987. Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs. Description of the model and local airway inflammation. Am. Rev. Respir. Dis. 135:433-440.
10. Walker, C., E. Bode, L. Boer, T. T. Hansel, K. Blaser, and J. C. Virchow, Jr. 1992. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am. Rev. Respir. Dis. 146:109-115.
11. + T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J. Allergy Clin. Immunol. 92:313-324.
12. Sanderson, C. J., H. D. Campbell, and I. G. Young. 1988. Molecular and cellular biology of eosinophil differentiation factor (interleukin-5) and its effects on human and mouse B cells. Immunol. Rev. 102:29-50.
13. Yamaguchi, Y., Y. Hayashi, Y. Sugama, Y. Miura, T. Kasahara, S. Kitamura, M. Torisu, S. Mita, A. Tominaga, and K. Takatsu. 1988. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J. Exp. Med. 167:1737-1742.
14. Corrigan, C. J., A. Haczku, V. Gemou Engesaeth, S. Doi, Y. Kikuchi, K. Takatsu, S. R. Durham, and A. B. Kay. 1993. CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Effect of glucocorticoid therapy. Am. Rev. Respir. Dis. 147:540-547.
15. Anderson, G. P., and A. J. Coyle. 1994. TH2 and "TH2-like" cells in allergy and asthma: pharmacological perspectives. Trends Pharmacol. Sci. 15:324-332.
16. Pepys, J., and B. J. Hutchcrooft. 1975. Bronchial provocation test in the etiologic diagnosis and analysis of asthma. Am. Rev. Respir. Dis. 112: 829-859.
17. Booiji-Noord, H., N. G. M. Orie, and K. de Vries. 1971. Immediate and late bronchial obstructive reactions to inhalation of house dust mite and provocative effects of disodium cromoglycate and prednisolone. J. Allergy Clin. Immunol. 48:344-354.
18. Robertson, D. G., A. T. Kerigan, F. E. Hargreave, R. Bhalmers, and J. Dolovichi. 1974. Late asthmatic response induced by ragweed allergen. J. Allergy Clin. Immunol. 54:244-254.
19. De Monchy, J. G., H. F. Kauffman, P. Venge, G. H. Koeter, H. M. Jansen, H. J. Sluiter, and K. De Vries. 1985. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am. Rev. Respir. Dis. 131:373-376.
20. Frew, A. J., R. Moqbel, M. Azzawi, A. Hartnell, J. Barkans, P. K. Jeffery, A. B. Kay, R. J. Scheper, J. Varley, M. K. Church, and S. T. Holgate. 1990. T lymphocytes and eosinophils in allergen-induced late-phase asthmatic reactions in the guinea pig. Am. Rev. Respir. Dis. 141:407-413.
21. Holgate, S. T., C. Hardy, C. Robinson, R. M. Agius, and P. H. Howarth. 1986. The mast cell as a primary effector cell in the pathogenesis of asthma. J. Allergy Clin. Immunol. 77:274-282.
22. Okayama, Y., C. Petit Frere, O. Kassel, A. Semper, D. Quint, M. J. Tunonde Lara, P. Bradding, S. T. Holgate, and M. K. Church. 1995. IgE-dependent expression of mRNA for IL-4 and IL-5 in human lung mast cells. J. Immunol. 155:1796-1808.
23. Bradding, P., I. H. Feather, S. Wilson, P. G. Bardin, C. H. Heusser, S. T. Holgate, and P. H. Howarth. 1993. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. J. Immunol. 151:3853-3865.
24. Galli, S. J. 1994. Mast cell-leukocyte cytokine cascade in allergy and inflammation. ACI News 6:126-127.
25. Bradding, P., J. A. Roberts, K. M. Britten, S. Montefort, R. Djukanovic, R. Mueller, C. H. Heusser, P. H. Howarth, and S. T. Holgate. 1994. Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am. J. Respir. Cell Mol. Biol. 10:471-480.
26. Martin, T. R., T. Takeishi, H. R. Katz, K. F. Austen, J. M. Drazen, and S. J. Galli. 1993. Mast cell activation enhances airway responsiveness to methacholine in the mouse. J. Clin. Invest. 91:1176-1182.
27. Gordon, J. R., and S. J. Galli. 1991. Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses. J. Exp. Med. 174:103-107.
28. + T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am. Rev. Respir. Dis. 146:374-377.
29. + T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am. J. Respir. Cell Mol. Biol. 10:587-593.
30. Gulbenkian, A. R., R. W. Egan, X. Fernandez, H. Jones, W. Kreutner, T. Kung, F. Payvandi, L. Sullivan, J. A. Zurcher, and A. S. Watnick. 1992. Interleukin-5 modulates eosinophil accumulation in allergic guinea pig lung. Am. Rev. Respir. Dis. 146:263-266.
31. Chand, N., J. E. Harrison, S. Rooney, J. Pillar, R. Jakubicki, K. Nolan, W. Diamantis, and R. D. Sofia. 1992. Anti-IL-5 monoclonal antibody inhibits allergic late phase bronchial eosinophilia in guinea pigs: a therapeutic approach. Eur. J. Pharmacol. 211:121-123.
32. Mauser, P. J., A. Pitman, A. Witt, X. Fernandez, J. Zurcher, T. Kung, H. Jones, A. S. Watnick, R. W. Egan, W. Kreutner, and G. K. Adams. 1993. Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. Am. Rev. Respir. Dis. 148:1623-1627.
33. Coligan, J. E., A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, editors. 1994. Current Protocols in Immunology. John Wiley & Sons, Inc., New York.
34. Gajewski, T. F., J. Joyce, and F. W. Fitch. 1989. Antiproliferative effect of IFN-gamma in immune regulation. III. Differential selection of TH1 and TH2 murine helper T lymphocyte clones using recombinant IL-2 and recombinant IFN-gamma. J. Immunol. 143:15-22.
35. Davidson, W. F., and C. R. Parish. 1975. A procedure for removing red cells and dead cells from lymphoid cell suspensions. J. Immunol. Methods 7:291-300.
36. + T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK506 and cyclosporin A. Int. Immunol. 7:449-457.
37. Schumacher, J. H., A. O'Garra, B. Shrader, A. van Kimmenade, M. W. Bond, T. R. Mosmann, and R. L. Coffman. 1988. The characterization of four monoclonal antibodies specific for mouse IL-5 and development of mouse and human IL-5 enzyme-linked immunosorbent. J. Immunol. 141:1576-1581.
38. Staub, N. C., and W. F. Storey. 1962. Relation between morphological and physiological events in lung studied by rapid freezing. J. Appl. Physiol. 17:381-390.
39. Konzett, H., and R. Rössler. 1940. Versuchsanordnung zu untersuchungen an der bronchialmuskulatur. Naunyn-Schmiedeberg's Arch. Exp. Pathol. Pharmacol. 195:71-74.
40. Shampain, M. P., B. L. Behrens, G. L. Larsen, and P. M. Hensen. 1982. An animal model of late pulmonary responses to Alternaria challenge. Am. Rev. Respir. Dis. 126:493-498.
41. Hershkoviz, R., O. Lider, D. Baram, T. Reshef, S. Miron, and Y. A. Mekori. 1994. Inhibition of T cell adhesion to extracellular matrix glycoproteins by histamine: a role for mast cell degranulation products. J. Leukoc. Biol. 56:495-501.
42. Newhouse, M. T. 1989. Aetiology of intrinsic asthma. In Intrinsic Asthma. M. Schmits-Schumann, G. Menz, U. Costabel, and C. P. Page, editors. Birkhauser-Verlag. 17-26.
43. Bentley, A. M., G. Menz, C. Storz, D. S. Robinson, B. Bradley, P. K. Jeffery, S. R. Durham, and A. B. Kay. 1992. Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial responsiveness. Am. Rev. Respir. Dis. 146:500-506.
44. Bentley, A. M., P. Maestrelli, M. Saetta, L. M. Fabbri, D. S. Robinson, B. L. Bradley, P. K. Jeffery, S. R. Durham, and A. B. Kay. 1992. Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma. J. Allergy Clin. Immunol. 89:821-829.
45. Okudaira, H., A. Mori, M. Suko, T. Etoh, H. Nakagawa, and K. Ito. 1995. Enhanced production and gene expression of interleukin-5 in patients with bronchial asthma: possible management of atopic diseases by down-regulation of interleukin-5 gene transcription. Int. Arch. Allergy Immunol. 107:255-258.